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Abstract 
Purpose: To determine the common uropathogens found in patients with urinary tract infections and to 
assess their antibiotic susceptibility patterns. 
Methods: The prevalence and antibiotic susceptibility pattern of E. coli in urinary tract infection in-
patients with renal failure disease and renal transplant recipients (group 1) and in outpatients (group 2), 
admitted in/attending Imam Reza Hospital in Tabriz, Iran, were determined. Isolates were analyzed by 
standard methods, and antimicrobial susceptibility testing was performed by Kirby-Bauer disc diffusion 
method. 
Results: A total of 136 E. coli strains from 81 females and 55 males were examined. The high level of 
antibiotic susceptibility for group 1 was cefuroxime/ceftazidime (100 %) and nitrofurantoin (81.63 %), 
respectively; and for group 2, it was ampicillin (95.83 %) and nitrofurantoin (93.75 %), respectively. 
Conclusion: The most important finding of this study is that a considerable proportion of the studied E. 
coli isolates are resistant to the antibiotics tested, except nitrofurantoin. This finding is useful for 
clinicians to determine appropriate empirical antimicrobial treatment in similar cases and would also 
help health authorities to formulate antibiotic prescription policies. 
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Escherichia coli (E. coli) is one of the most 
important causes of community-acquired and 
nosocomial infections. This organism is therefore 
of clinical importance and can be isolated from 
various clinical specimens [1]. Urinary tract 
infections (UTIs), including cystitis and 
pyelonephritis, are the most common infectious 
diseases in childhood. E. coli accounts for as 
much as 90 % of the community-acquired and 50 
% of the nosocomial UTIs [2,3]. 
 
Knowledge of antimicrobial resistance pattern in 
E. coli, the predominant pathogen associated 
with urinary tract infection is important as a guide 
in selecting empirical antimicrobial therapy. 
Microbial infections are one of the major 
problems militating against successful organ 
transplantation and can cause high morbidity and 
mortality among transplant recipients. Infections 
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in renal transplant recipients account for 26 % of 
hospitalization days annually and 40 % of overall 
mortalities [4]. Although UTI is one of the most 
common bacterial diseases in children, its 
diagnosis is often delayed due to obscure clinical 
findings. In pediatric patients, acute 
pyelonephritis may be associated with high 
morbidity and long-term complications like renal 
scarring, hypertension, and chronic renal failure 
[5-7]. 
 
Gram-negative enteric bacilli, especially E. coli 
and Klebsiella spp., are the leading pathogens, 
though Enterococcus spp., yeasts, and 
Staphylococcus spp. have recently emerged as 
prominent agents [5]. Worldwide, 150 million 
people are diagnosed with UTI each year, 
costing the global economy in excess of US$ 6 
billion [8]. In the United States, surveys have 
estimated an incidence of 8 million UTI episodes 
per year [9]. A study from Turkey showed that 
17.8 % of all visits were patients with UTI at 
primary care settings [10]. 
 
The predominance of Gram-negative species, 
usually Enterobacteriaceae and, particularly, 
Escherichia coli, remained the principal 
pathogens causing UTI, accounting for 75 – 90 
% of all urinary tract infections in both inpatients 
and outpatients [11]. The in vitro susceptibility of 
E. coli urinary isolates to the most common 
antimicrobial agents used for the treatment of 
patients with UTI varies considerably in different 
parts of the world [12-14]. Antibiotics are usually 
given empirically before laboratory results from 
urine culture are available. To optimize the use of 
empirical antibiotic therapy for UTI, it is important 
for clinicians to be aware of the etiological agents 
and susceptibility patterns of UTI pathogens in 
their populations. Hence, various centers 
consider the results of urine culture previously 
obtained from their microbiology laboratory in 
selecting empirical antibiotic treatment for UTI 
[15]. 
 
The aim of this study was to investigate microbial 
species isolated from patients with UTI and 
evaluate E. coli prevalence and antibiotic 
susceptibility pattern in patients with renal failure 
disease and renal transplant recipients 






Urinary specimens were obtained from renal 
failure transplant and failure patients and 
outpatients. For each patient, age, sex, collection 
date, prescribed antibiotic and hospitalization 
period was registered. 
 
Ten ml of midstream clean urine specimens were 
collected in sterile containers and transported to 
the laboratory in minimum time for analysis and 
culturing on appropriate bacteriologic media [16]. 
 
Macroscopic and microscopic examination 
 
For macroscopic examination color and 
appearance of collected urine samples was 
observed and reported accordingly.  
 
In microscopic examination, centrifuging at 300 
rpm for 10 min, preparation of wet mount smear 
and gram stain was done for directly 
examination. 
 
Urine culturing and bacterial identification  
 
Urine specimen was used for culturing on sheep 
blood and MacConkey agar plates by calibrated 
loop of 1 µL and incubated at 37 °C for 24 h. 
Specimens with more than 105 colony forming 
unit (CFU) per ml were considered as positive 
samples.  
 
All isolates were identified morphologically and 
biochemically by standard laboratory procedures 
(Baird D. Staphylococcus). 
 
Antibiogram test  
 
Antimicrobial susceptibility test was performed 
according to “Kirby & Bauer” method on Mueller-
Hinton agar medium [17]. The agents used for 
antibiotic susceptibility testing of isolates are 
amikacin, ampicilin, cefixime, ceftazidime, 
ceftriaxone, cefuroxime, chloramphenicol, 
ciprofloxacin, cotrimaxazole, imipenem, nalidixic 
acid, nitrofurantoin, ofloxacin, tetracycline and 
trimethoprim. E. coli (ATCC 25922) was used as 




Data collected in this study were evaluated by 
one-way analysis of variance (ANOVA) using 





A total of 136 urinary specimens from different 
patients were obtained from 68 renal transplant 
and failure patients and 68 outpatients 
hospitalized in Tabriz Emam Reza hospital.  
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They were 55 males (40.44 %) and 81females 
(59.55 %) with different ages from 9 to 75. Out of 
136 bacterial isolates from the patients, the rate 
of E. coli (98, 72.05 %) isolation was highest, as 
shown in Table 1. 
 
Table 2 depicts the antibiotic susceptibility data 
for all the E. coli isolates in renal transplant and 
failure patients (group 1) and outpatients (group 
2). 
 
The antibiotic susceptibility pattern for E. coli 
isolated from group 1 showed the highest 
resistance to cefuroxime and ceftazidime (100 
%) followed by ceftriaxone (97.9 %) and 
ciprofloxacin (95 %), while group 2 showed the 
highest resistance to ampicilin (95.83 %) 
followed by cefuroxime (91.66 %) and 
ceftazidime (89.58 %). In order of efficacy 
nitrofurantoin was the most effective in groups 1 





This study shows the prevalence and antibiotic 
susceptibility pattern of E. coli isolated from 
urinary tract infection in patients with renal failure 
disease and renal transplant recipients at Imam 
Reza hospital in Tabriz, Iran.  
 
Antimicrobial resistance is a growing problem 
and a cause of great concern throughout the 
world [18]. Approximately 1 in 3 women will 
require antimicrobial treatment for a UTI before 
age 24, and 40 % to 50 % of women will suffer 
from UTI during their lifetime [19]. In the last 
decades, the number of reports about 
appearance of bacteria with antibiotic resistance 
has increased all over the world [20]. This study, 
like others, shows clearly that there are 
significant geographic differences in the 
susceptibility of commonly used antimicrobials 
against UTIs [21]. Knowledge of antimicrobial 
resistance trends among isolates of 
uropathogens is essential to provide clinically 
appropriate and cost-effective therapy. 
Guidelines for the empirical treatment of patients 
with UTI suggest it is important to consider local 
resistance patterns of commonly isolated 
pathogens in selecting the antibiotic agents. This 
study provides an update on E. coli, the main 
cause of UTI in outpatients. Ampicillin or 
amoxicillin were once standard therapy for UTI, 
but resistance of E. coli to ampicillin has been on 
the increase in most regions of the world [22-24]. 
 
                    Table 1: Frequency of isolates in studied population 
 
Microorganism Renal failure and 
transplant patients Outpatients 
No. % No. % 
E. coli 49 72.05 46 67.64 
Staphylococcus aureus 5 7.35 3 4.41 
Serratia 1 1.47 1 1.47 
Enterococcus 3 4.41 4 5.88 
Klebsiella 5          7.35 4 5.88 
Pseudomonas 5 7.35 7 10.29 
Staphylococcus epidermidis 0 0 3 4.41 
 
          Table 2: Antibiotic sensitivity pattern of E. coli isolates 
 
Antibiotic Code Disk (µg) 
Group 1 Group 2 
Resistant (%) Sensitive (%) Resistant (%) Sensitive (%) 
Ampicilin AP 10 87.75 12.24 95.83 4.16 
Cotrimaxazole TS 25 81.63 18.36 60.41 39.58 
Tetracycline T 30 85.71 14.28 54.16 45.83 
Nalidixic Acid NA 30 89.79 10.2 85.41 14.58 
Cefuroxime CXM 30 100 0 91.66 8.3 
Ceftriaxone CRO 30 97.9 2.04 64.58 35.41 
Imipenem IMI 10 20.4 79.59 10.41 89.58 
Nitrofurantoin NI 300 18.36 81.63 6.25 93.75 
Amikacin AK 30 32.65 67.34 25 75 
Chloramphenicol C 30 36.73 63.26 8.3 87.5 
Cefixime CFM 5 85.71 14.28 66.66 33.33 
Ceftazidime CAZ 30 100 0 89.58 10.41 
Ciprofloxacin CIP 5 95 4.08 27.08 72.91 
Trimethoprim TM 5 85.71 14.28 81.25 18.75 
Ofloxacin OFX 30 81.63 18.36 79.16 20.83 
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The present study demonstrated that the 
prevalence of ampicillin resistance was 87.75 
and 95.83 % for renal failure and transplant 
patients and outpatients, respectively. 
 
A urine specimen for culture obtained before the 
initiation of antimicrobial therapy confirms the 
diagnosis of UTI. The choice of antibiotics 
depends upon the causative organism and its 
local expected antibiotic susceptibility pattern. 
Comparisons of the findings of the present study 
with those of other recent similar studies indicate 
similarity. 
 
Findings in this study are similar to those of 
previous studies for USA [21] and Iran [25]. 
Reports from developed and developing nations 
such as Turkey, Senegal, Brazil, Slovenia, 
Southern India and Australia are also consistent 
with the present findings [11,26-28].  
 
The lack of sufficient data about bacterial 
resistance to the antimicrobial agents in 
developing countries, including Iran, may be 
responsible for the increasing emergence of 




Findings from this study demonstrate that 
nitrofurantoin and imipenem can be used as first- 
and second-line empirical treatments of 
pathogenic E. coli in Tabriz, Iran. However, this 
recommendation also requires careful and 
extensive monitoring at healthcare centers to 





The authors would like to acknowledge the staff 
of Department of Bacteriology and Virology, 
School of Medicine, Tabriz University of Medical 
Sciences for their technical support during the 




1. Umolu PI, Okoli EN, Izomoh IM. Antimicrobial 
susceptibility and Escherichia coli isolates obtained 
from different human clinical specimens in Lagos – 
Nigeria. J Am Sci 2006; 2: 70–76. 
2. Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, 
Barranco M, Moreno A, Mensa J. Are quinolone-
resistant uropathogenic Escherichia coli less virulent? 
J Infect Dis 2002; 186: 1039–1042. 
3. Svanborg C, Godaly G. Bacterial virulence in urinary tract 
infection. Infect Dis Clin North Am 1997; 11: 513–
529. 
4. Kee T, Lu YM, Vathsala A. Spectrum of severe infections 
in an Asian renal transplant population. Transplant 
Proc 2004; 36: 2001-2003. 
5. Haller M, Brandis M, Berner R. Antibiotic resistance of 
urinary tract pathogens and rationale for empirical 
intravenous therapy. Pediatr Nephrol 2004; 19(9): 
982-986. 
6. Jakobsson B, Berg U, Svensson L. Renal scarring after 
acute pyelonephritis. Arch Dis Child 1994; 70(2): 111-
115. 
7. Taneja N, Chatterjee SS, Singh M, Singh S, Sharma M. 
Pediatric urinary tract infections in a tertiary care 
center from north India. Indian J Med Res 2010; 131: 
101-105 
8. Stamm WE, Norrby RS. Urinary tract infections: disease 
panorama and challenges. J Infect Dis 2001; 183: 
S1–S4 
9. Foxman B. Epidemiology of urinary tract infections: 
incidence, morbidity, and economic costs. Dis Mon 
2003; 49(2): 53-70. 
10. Cambaz S, Peksen Y, Tevfi k, Sunter A, Leblebicioglu H, 
Sunbul M. Antibiotic prescribing and urinary tract 
infection. Int J Antimicrob Agents 2002; 20(6): 407–
411 
11. Dromigny JA, Nabeth P, Juergens-Behr A, PerrierGros-
Claude JD. Risk factors for antibiotic resistant 
Escherichia coli isolated from community-acquired 
urinary tract infections in Dakar, Senegal. J 
Antimicrob Chemother 2005; 56: 236-239. 
12. Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, 
Nichol KA, Weshnoweski B, Johnson J, Noreddin A, 
Low DE, Karlowsky JA, Hoban DJ. Antibiotic 
resistance in Escherichia coli outpatient urinary 
isolates: results from the North American Urinary 
Tract infection Collaborative Alliance (NAUTICA). Int 
J Antimicrob Agents 2006; 27: 468–475 
13. Kahlmeter G, An international survey of the antimicrobial 
susceptibility of pathogens from uncomplicated 
urinary tract infections: the ECO. SENS Project. J 
Antimicrob Chemother 2003; 51: 69–76 
14. Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari 
AC, Gales AC. Increased resistance to fi rst-line 
agents among bacterial pathogens isolated from 
urinary tract infections in Latin America: time for local 
guidelines? Mem Inst Oswaldo Cruz, Rio de Laneiro, 
2006; 101(7): 741–748 
15. Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, 
Betlejewska K, Hryniewicz W. Antibiotic susceptibility 
of bacterial strains isolated from urinary tract 
infections in Poland. J Antimicrob Chemother 2001; 
47(6): 773-780. 
16. Nadia Gul, Talat Y. Mujahid, Samira Ahmad. Isolation, 
Identification and Antibiotic Resistance Profile of 
Indigenous Bacterial Isolates from Urinary Tract 
Aghazadeh et al 
Trop J Pharm Res, April 2015; 14(4):   
 
653 
Infection Patients. Pak J Bio Sci 2004; 7(12): 2051-
2054 
17. Farshad S, Ranjbar R, Anvarinejad M, Shahidi MA, 
Hosseini M. Emergence of Multi Drug Resistant 
Strains of Eschetichia coli Isolated from Urinary Tract 
Infection. Open Conf Proc J. 2010; 1: 192-196. 
18. Ghotaslou R, Yaghoubi A, Sharify S. Urinary Tract 
Infections in Hospitalized Patients during 2006 to 
2009 in. J Cardiovasc Thorac Res 2010; 2(1): 39-42. 
19. Foxman B. Epidemiology of urinary tract infections: 
incidence, morbidity, and economic costs. Am J Med 
2002; 113: 5S–13S 
20. Ranjbar R, Haghi-Ashtiani M, Jafari NJ, Abedini M. The 
prevalence and antimicrobial susceptibility of 
bacterial uropathogens isolated from pediatric 
patients. Iranian J Pub Health 2009; 38(2): 134-138. 
21. Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility 
of bacterial strains isolated from patients with 
community-acquired urinary tract infections. Int J 
Antimicrob Agents 2001; 18(3): 211-215. 
22. Dromigny JA, Nabeth P, Juergense BA, Gros-Claude 
JDP. Risk factors for antibiotic- resistant Escherichia 
coli isolated from community acquired urinary tract 
infection in Dakor, Senegal. J Antimicrob Chemother 
2005; 33: 89-94. 
23. Randrianirina F, Soares JL, Carod JF, Ratsima E, 
Thonnier V, Combe P, Grosjean P, Talarmin A. 
Antimicrobial resistance among uropathogens that 
cause community-acquired urinary tract infections in 
Antananarivo, Madagascar. J Antimicrob Chemother, 
2007; 59: 309–312 
24. Uzunkovic-Kamberovic S. Antibiotic resistance of coliform 
organisms from community-acquired urinary tract 
infections in Zenica-Doboj Canton, Bosnia and 
Herzengovina. J Antimicrob Chemother 2006; 58: 
344–348 
25. Amin M, Mehdinejad M, Pourdangchi Z. Study of bacteria 
isolated from urinary tract infections and 
determination of their susceptibility to antibiotics. 
Jundishapur J Microbiol 2011; 2(3): 118-123. 
26. Guidoni EBM, Berezin EN, Nigro S, Santiago NA, Benini 
V, Toporovski J. Antibiotic resistance patterns of 
pediatric community acquired urinary infection. Braz J 
Infect Dis 2008; 12: 321-323. 
27. Yuksel S, Ozturk B, Kavaz A, Ozcakar ZB, Acar B, Guriz 
H, Aysev D, Ekim M, Yalçınkaya F. Antibiotic 
resistance of urinary tract pathogens and evaluation 
of empirical treatment in Turkish children with urinary 
tract infection. Int J Antimicrob Agent 2006; 28: 413-
416. 
28. Mehr SS, Powell CV, Curtis N. Cephalosporin resistant 
urinary tract infection in young children. J Paediatr 
Child Health 2004; 40(1-2): 48-52. 
29. Ebrahimzadeh MA, Mahdavee MR, Vahedi M. Antibiotic 
resistance in E. coli isolated from urine: A2-years 
study isolated from patient with urinary tract infections 
in Iran. J Cell Tissue Res 2005; 5(2): 445-448. 
 
